Fortimel Compact Protein includes a sensational range of five tailor-made flavors designed to support cancer patients struggling with sensory alterations.
Product description
Fortimel Compact Protein is a food for special medical purposes for the dietary management of disease related malnutrition.
For use under medical supervision only, Fortimel Compact Protein is a high protein, high energy medical nutrition supplement. It contains all essential minerals, vitamins and trace elements, providing 18 g of protein and 306 kcal in 125 ml.
Available in the following flavours: Neutral, Banana, Berries, Mocha, Peach, Mango, Strawberry, Vanilla, Cool red fruits and Hot tropical ginger. The flavours Neutral, Cool red fruits and Hot tropical ginger were co-built with cancer patients experiencing taste alteration.
Product information
Water, cow’s milk proteins, maltodextrin, sugar, vegetable oils (rapeseed oil, sunflower oil), magnesium hydrogen phosphate, emulsifier (soy lecithin), flavouring, choline chloride, sodium L-ascorbate, potassium citrate, di potassium hydrogen phosphate, ferrous lactate, DL-α-tocopheryl acetate, colouring (curcumin), retinyl acetate, copper gluconate, zinc sulphate, manganese sulphate, calcium D-pantothenate, sodium selenite, D-biotin, chromium chloride, cholecalciferol, thiamin hydrochloride, pteroylmonoglutamic acid, pyridoxine hydrochloride, nicotinamide, potassium iodide, riboflavin, sodium molybdate, sodium fluoride, cyanocobalamin, phytomenadione
Allergy advice: for allergens see ingredients in bold.
| Average contents | per 100 ml |
|---|---|
| Energy: | 1010kJ/240kcal |
| Fat: | 9.4g (35 En%) |
| saturates | 0.9g |
| Carbohydrate: | 24.4g (41 En%) |
| - Sugars | 13.3g |
| - Lactose | 0.3g |
| Fibre: | 0g (0 En%) |
| Protein: | 14.4g (24 En%) |
| Salt: | 0.10g |
| Vitamins: | |
| Vit A | 260μg |
| Vit D | 2.1μg |
| Vit E | 3.7mg (α-TE/ET) |
| Vit K | 16μg |
| Thiamin | 0.45mg |
| Riboflavin | 0.50mg |
| Niacin | 0.59mg (3.6mg NE/EN) |
| Pantothenic acid | 1.6mg |
| Vit. B6 | 0.53mg |
| Folic acid | 80μg |
| Vit. B 12 | 1.1μg |
| Biotin | 12μg |
| Vit. C | 30mg |
| Minerals and trace elements: | |
| Na | 40mg (1.7 mmol) |
| K | 105mg (2.7 mmol) |
| Cl | 60mg (1.7 mmol) |
| Ca | 350mg (8.7 mmol) |
| P | 300mg (9.7 mmol) |
| PO4 | 914mg (8.7 mmol) |
| Mg | 55mg (9.7 mmol) |
| Fe | 2.1mg (9.7 mmol) |
| Zn | 2.4mg (2.3 mmol) |
| Cu | 0.35mg |
| Mn | 0.63mg |
| F | 0.19mg |
| Mo | 20μg |
| Se | 14μg |
| Cr | 13μg |
| l | 46μg |
| Others: | |
| Choline | 110mg |
| Osmolarity | 570mOsmol/l |
How does Fortimel Compact Protein address taste changes?
Protein is an important nutrient at every stage of the cancer journey
Protein is an important nutrient at every stage of the cancer journey. In patients with cancer, the need for protein is higher than for healthy adults, and cancer patients often fail to consume sufficient protein2-4. Low protein intake can lead to low muscle mass, fatigue and even poorer survival in patients with cancer5-8. Therefore, ensuring sufficient protein with high protein oral nutritional supplements can improve clinical outcomes9-13.
Taste can change outcomes shouldn’t
Up to 70% of cancer patients experience taste and smell alterations14. Sensory changes in cancer contribute to weight loss and malnutrition, increasing the risk of poor clinical outcomes15-22. Sensory-adapted oral nutritional supplements, such as the Fortimel Compact Protein Sensational flavor range, have been designed and validated with cancer patients experiencing taste and smell alterations.
- Ryan et al. Proc Nutr Soc. 2016;75(2):199-211.
- Prado et al. Canadian journal of dietetic practice and research 2012; 73(4):e298-303
- McCurdy et al. Nutrients 2019; 11(11)
- Stobaus et al. Nutr Cancer 2015; 67(5):818-24
- Tobberup et al. Clin Nutr ESPEN 2019; 34:94-100
- Capitao et al. Support care cancer 2022; 30(4):3007-3015
- Regueme et al. Support Care Cancer 2021; 29(2):687-696
- Hasegawa et al. Clin Nutr 2021; 40(7):4792-4798
- Kabata et al. Supportive Care in Cancer 2014; 23, 365-370
- Cereda et al. Radiother Oncol 2018; 126(1):81-88
- Grupinska et al. Nutrients 2021; 13, 3549
- Meng et al. Clin Nutr 2021; 40(1):40-46
- Manasek et al. Kin Onkol 2016; 29(5):351-357
- Spotten et al. Ann Oncol 2017; 28:969-84
- Ryan et al. Nutrition 2019; 67-68:110539
- Pressoir et al. Br J Cancer 2010; 102 (6), 966-71
- Drareni et al. Semin Oncol 2019; 46:160-72
- Brisbois et al. J Pain Symptom Manage 2011; 41:673-83
- Boltong et al. Support Care Cancer 2012; 20:2765-74
- Belqaid et al. Acta Oncol 2014; 53:1405-12
- Prado et al. Canadian journal of dietetic practice and research 2012; 73(4):e298-303
- McCurdy et al. Nutrients 2019; 11(11)
- Cookie Statement
- Privacy Statement
- Terms of Use
- Danone Ethics Line
- Site Map
Are you a healthcare professional or (carer of) a diagnosed patient?
The product information for this area of specialization is intended for healthcare professionals or (carers of) diagnosed patients only, as these products are for use under healthcare professional supervision.
Please click ‘Yes’ if you are a healthcare professional or (carer of) a diagnosed patient, or ‘No’ to be taken to a full list of our products.
The information on this page is intended for healthcare professionals only.
If you aren't a healthcare professional, you can visit the page with general information, by clicking 'I'm not a healthcare professional' below.